Another long-standing concern of many foreign companies operating in China is forced technology transfers. The chamber said 19 per cent of the companies surveyed – in sectors such as aviation, cars, chemicals and engineering – felt compelled to transfer technology.
Meanwhile, 43 per cent said they had found it more difficult getting access to the sectors listed under the Made in China 2025 policy, although access had improved for larger European firms, particularly in cars and machinery.
Companies surveyed identified the top regulatory obstacles as unfavourable treatment in dealing with administrative issues, discrimination in enforcement of rules, market access barriers and licensing requirements. Legal services, pharmaceutical and medical devices were among the sectors that reported the most cases of unfair treatment.